ArticleOncotarget2016

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.

Zheng Ping et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.